| Date Filed | Type | Description |
| 08/14/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 14.3% stake in Arco Platform Ltd. |
| 07/11/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 5.9% stake in Immunocore Holdings plc |
| 06/09/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 7.1% stake in XP Inc. |
| 05/02/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/31/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 14.5% stake in Arco Platform Ltd. |
| 03/23/2023 |
SC 13D
| GENERAL ATLANTIC, L.P. reports a 37.9% stake in DLocal Limited |
| 02/28/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 0% stake in CinCor Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| GENERAL ATLANTIC, L.P. reports a 12.7% stake in Clear Secure, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/11/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 9.6% stake in CinCor Pharma, Inc. |
| 01/11/2023 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 14% stake in Arco Platform Ltd. |
| 12/23/2022 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 15.2% stake in China Index Holdings Limited |
| 12/20/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/09/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/30/2022 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 9.3% stake in Arco Platform Ltd. |
| 11/28/2022 |
SC 13D/A
| GENERAL ATLANTIC, L.P. reports a 15.2% stake in China Index Holdings Limited |
| 11/07/2022 |
SC 13G
| GENERAL ATLANTIC, L.P. reports a 10.4% stake in Mobileye Global Inc. |
| 09/28/2022 |
SC 13D
| GENERAL ATLANTIC, L.P. reports a 7.3% stake in Third Harmonic Bio, Inc. |
| 08/24/2022 |
SC 13D
| GENERAL ATLANTIC, L.P. reports a 5.7% stake in XP Inc. |
| 07/21/2022 |
SC 13D
| GENERAL ATLANTIC, L.P. reports a 11.5% stake in Immunocore Holdings plc |
| 06/24/2022 |
SC 13G
| GENERAL ATLANTIC, L.P. reports a 9.9% stake in Grove Collaborative Holdings, Inc. |
|